Alkermes plc. Logo

Alkermes plc.

Develops and commercializes medicines for central nervous system (CNS) diseases.

ALKS | US

Overview

Corporate Details

ISIN(s):
IE00B56GVS15 (+1 more)
LEI:
Country:
United States of America
Address:
CONNAUGHT HOUSE, 0 DUBLIN 4

Description

Alkermes plc is a global biopharmaceutical company that develops and commercializes medicines for diseases of the central nervous system (CNS). The company's research and development efforts focus on complex psychiatric and neurological disorders. Its portfolio includes treatments for conditions such as schizophrenia, bipolar I disorder, alcohol dependence, and opioid dependence. Alkermes' clinical-stage pipeline features investigational therapies, including orexin 2 receptor agonists for sleep disorders like narcolepsy and idiopathic hypersomnia. The company's commercialized products include olanzapine and samidorphan, an oral atypical antipsychotic drug for adults with schizophrenia or bipolar I disorder.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2026-01-09 01:38 English ZIP 7.2 KB
2026-01-08 23:23
PRIMARY DOCUMENT
English ZIP 7.6 KB
2026-01-06 13:06
8-K
English ZIP 70.8 KB
2026-01-02 22:39
PRIMARY DOCUMENT
English ZIP 6.7 KB
2026-01-02 22:36 English ZIP 7.3 KB
2025-12-05 22:21
PRIMARY DOCUMENT
English ZIP 7.6 KB
2025-12-03 22:32 English ZIP 7.2 KB
2025-12-01 23:41
PRIMARY DOCUMENT
English ZIP 6.7 KB
2025-12-01 22:45 English ZIP 7.2 KB
2025-11-19 12:28
8-K
English ZIP 869.1 KB
2025-11-12 14:45
8-K
English ZIP 7.0 MB
2025-11-03 22:37
PRIMARY DOCUMENT
English ZIP 7.6 KB
2025-11-03 22:35 English ZIP 7.3 KB
2025-10-28 14:20
10-Q
English ZIP 3.4 MB
2025-10-28 12:05
8-K
English ZIP 5.0 MB

Automate Your Workflow. Get a real-time feed of all Alkermes plc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Alkermes plc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Alkermes plc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Ascelia Pharma Logo
Biotechnology company developing and commercializing novel drugs for orphan oncology.
Sweden
ACE
Ascendis Pharma A/S Logo
Biopharmaceutical firm using its prodrug technology to treat rare diseases.
United States of America
ASND
ASCENTAGE PHARMA GROUP INTERNATIONAL Logo
A clinical-stage biopharma developing novel therapies for cancer and other diseases.
United States of America
AAPG
Specializes in hormone-related pharmaceuticals for internal medicine, OB/GYN, and urology.
Japan
4886
Aspire Biopharma Holdings, Inc. Logo
Develops sublingual drug delivery technologies for needle-free medications.
United States of America
ASBP
ASSEMBLY BIOSCIENCES, INC. Logo
A clinical-stage biotech developing small molecule antiviral therapeutics for viral diseases.
United States of America
ASMB
Assertio Holdings, Inc. Logo
Pharmaceutical company managing branded products for neurology and orphan diseases.
United States of America
ASRT
Astellas Pharma Inc. Logo
A global pharmaceutical company turning innovative science into value for patients.
Japan
4503
AstraZeneca PLC Logo
A global, science-led biopharmaceutical company developing prescription medicines.
United Kingdom
AZN
Astria Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapies for allergic and immunologic diseases.
United States of America
ATXS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.